Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-17

Clinical Trial Update: Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09 [Phase 2]

View source ↗

Summary

Phase 2 trial update on hypofractionated 3-Dimensional radiation therapy for newly diagnosed stages I-III non-small cell lung cancer (ICORG 99-09) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED